Literature DB >> 27975103

Reasons for the persistent incidence of venous thromboembolism.

John A Heit1, Aneel Ashrani, Daniel J Crusan, Robert D McBane, Tanya M Petterson, Kent R Bailey.   

Abstract

Reasons for trends in venous thromboembolism (VTE) incidence are uncertain. It was our objective to determine VTE incidence trends and risk factor prevalence, and estimate population-attributable risk (PAR) trends for each risk factor. In a population-based cohort study of all residents of Olmsted County, Minnesota from 1981-2010, annual incidence rates were calculated using incident VTE cases as the numerator and age- and sex-specific Olmsted County population estimates as the denominator. Poisson regression models were used to assess the relationship of crude incidence rates to year of diagnosis, age at diagnosis, and sex. Trends in annual prevalence of major VTE risk factors were estimated using linear regression. Poisson regression with time-dependent risk factors (person-years approach) was used to model the entire population of Olmsted County and derive the PAR. The age- and sex-adjusted annual VTE incidence, 1981-2010, did not change significantly. Over the time period, 1988-2010, the prevalence of obesity, surgery, active cancer and leg paresis increased. Patient age, hospitalisation, surgery, cancer, trauma, leg paresis and nursing home confinement jointly accounted for 79 % of incident VTE; obesity accounted for 33 % of incident idiopathic VTE. The increasing prevalence of obesity, cancer and surgery accounted in part for the persistent VTE incidence. The PAR of active cancer and surgery, 1981-2010, significantly increased. In conclusion, almost 80 % of incident VTE events are attributable to known major VTE risk factors and one-third of incident idiopathic VTE events are attributable to obesity. Increasing surgery PAR suggests that concurrent efforts to prevent VTE may have been insufficient.

Entities:  

Keywords:  Venous thrombosis; epidemiology; phlebitis; pulmonary embolism; thrombophlebitis

Mesh:

Year:  2016        PMID: 27975103      PMCID: PMC5597250          DOI: 10.1160/TH16-07-0509

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  31 in total

1.  Limitations of administrative databases.

Authors:  Elliott R Haut; Peter J Pronovost; Eric B Schneider
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

2.  Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study.

Authors:  A Delluc; D Mottier; G Le Gal; E Oger; K Lacut
Journal:  J Thromb Haemost       Date:  2009-01-13       Impact factor: 5.824

3.  The patient record in epidemiology.

Authors:  L T Kurland; C A Molgaard
Journal:  Sci Am       Date:  1981-10       Impact factor: 2.142

4.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

5.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

6.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

Review 7.  Venous thromboembolism: disease burden, outcomes and risk factors.

Authors:  J A Heit
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

8.  Age trends in autopsy rates. Striking decline in late life.

Authors:  J C Ahronheim; A S Bernholc; W D Clark
Journal:  JAMA       Date:  1983-09-02       Impact factor: 56.272

9.  Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort.

Authors:  Cynthia L Leibson; Jack Needleman; Peter Buerhaus; John A Heit; L Joseph Melton; James M Naessens; Kent R Bailey; Tanya M Petterson; Jeanine E Ransom; Marcelline R Harris
Journal:  Med Care       Date:  2008-02       Impact factor: 2.983

Review 10.  How I treat isolated distal deep vein thrombosis (IDDVT).

Authors:  Gualtiero Palareti
Journal:  Blood       Date:  2014-01-28       Impact factor: 22.113

View more
  22 in total

1.  Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US.

Authors:  John A Heit; Daniel J Crusan; Aneel A Ashrani; Tanya M Petterson; Kent R Bailey
Journal:  Blood       Date:  2017-05-08       Impact factor: 22.113

Review 2.  Short- and Long-term Mortality Risk After Acute Pulmonary Embolism.

Authors:  Rajesh Gupta; Dylan D Fortman; Daniel R Morgenstern; Christopher J Cooper
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

3.  Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism.

Authors:  Brett J Carroll; Samuel Z Goldhaber; Ping-Yu Liu; Gregory Piazza
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

4.  Conditional catheter-related thrombosis free probability and risk-adapted choices of catheter for lung cancer.

Authors:  Yanfeng Wang; Chanjuan Cui; Xin Liu; Lei Deng; Ke Yang; Bin Li; Jie Xue; Junying Xie; Wei Cui
Journal:  Thorac Cancer       Date:  2022-05-13       Impact factor: 3.223

5.  Modeling Time to Cure of Deep Vein Thrombosis Using Cox Proportional Model in Southwest of Ethiopia.

Authors:  Gurmessa Nugussu Gelcho; Mosisa Girma Bekele
Journal:  Ethiop J Health Sci       Date:  2022-05

Review 6.  Obesity and Pulmonary Hypertension.

Authors:  Karnika Ayinapudi; Twinkle Singh; Ayush Motwani; Thierry H Le Jemtel; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2018-10-05       Impact factor: 5.369

7.  Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival among Olmsted County Residents of Local Nursing Homes.

Authors:  Tanya M Petterson; Carin Y Smith; Jane A Emerson; Kent R Bailey; Aneel A Ashrani; John A Heit; Cynthia L Leibson
Journal:  Thromb Haemost       Date:  2018-07-02       Impact factor: 5.249

8.  A large-scale exome array analysis of venous thromboembolism.

Authors:  Sara Lindström; Jennifer A Brody; Constance Turman; Marine Germain; Traci M Bartz; Erin N Smith; Ming-Huei Chen; Marja Puurunen; Daniel Chasman; Jeffrey Hassler; Nathan Pankratz; Saonli Basu; Weihua Guan; Beata Gyorgy; Manal Ibrahim; Jean-Philippe Empana; Robert Olaso; Rebecca Jackson; Sigrid K Braekkan; Barbara McKnight; Jean-Francois Deleuze; Cristopher J O'Donnell; Xavier Jouven; Kelly A Frazer; Bruce M Psaty; Kerri L Wiggins; Kent Taylor; Alexander P Reiner; Susan R Heckbert; Charles Kooperberg; Paul Ridker; John-Bjarne Hansen; Weihong Tang; Andrew D Johnson; Pierre-Emmanuel Morange; David A Trégouët; Peter Kraft; Nicholas L Smith; Christopher Kabrhel
Journal:  Genet Epidemiol       Date:  2019-01-19       Impact factor: 2.344

9.  Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study.

Authors:  Damon E Houghton; Aneel Ashrani; David Liedl; Ramila A Mehta; David O Hodge; Thom Rooke; Paul Wennberg; Waldemar Wysokinski; Robert McBane
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

10.  Incidence of venous thromboembolism in Korea from 2009 to 2013.

Authors:  Junshik Hong; Ju Hyun Lee; Ho-Young Yhim; Won-Il Choi; Soo-Mee Bang; Heeyoung Lee; Doyeun Oh
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.